Spark Investment Management’s Fortress Biotech FBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-796
Closed -$16K 550
2019
Q3
$16K Sell
796
-67
-8% -$1.57K ﹤0.01% 388
2019
Q2
$19K Buy
+863
New +$22.2K ﹤0.01% 543
2019
Q1
Sell
-5,353
Closed -$69K 669
2018
Q4
$69K Sell
5,353
-1,367
-20% -$22.8K ﹤0.01% 585
2018
Q3
$161K Sell
6,720
-300
-4% -$9.6K 0.01% 586
2018
Q2
$313K Buy
7,020
+707
+11% +$39.8K 0.02% 494
2018
Q1
$430K Sell
6,313
-1,367
-18% -$86.5K 0.03% 417
2017
Q4
$459K Buy
7,680
+660
+9% +$38.9K 0.02% 466
2017
Q3
$465K Buy
+7,020
New +$473K 0.02% 496
2015
Q3
Sell
-2,860
Closed -$144K 698
2015
Q2
$144K Sell
2,860
-8,093
-74% -$415K 0.02% 571
2015
Q1
$632K Buy
10,953
+8,446
+337% +$352K 0.09% 321
2014
Q4
$89K Buy
+2,507
New +$73.8K 0.02% 591

Other funds holding FBIO

Spark Investment Management's FBIO Position: Q4 2019 in Review

Spark Investment Management sold out of Fortress Biotech (FBIO) in Q4 2019, closing a stake of 796 shares — an estimated $16K sold.

Spark Investment Management first reported a position in FBIO in Q4 2014 and held it in 11 quarters. The position peaked at $632K in Q1 2015. 54 funds tracked by Wall St. Rank hold FBIO as of Q4 2019.

  • Spark Investment Management reported no remaining Fortress Biotech position as of Q4 2019 after selling out during the quarter.
  • Spark Investment Management sold 796 Fortress Biotech shares in Q4 2019, an estimated $16K.
  • Spark Investment Management first reported a position in Fortress Biotech in Q4 2014 and held it in 11 quarters.
  • Spark Investment Management's Fortress Biotech position peaked at $632K in Q1 2015.
  • 54 funds tracked by Wall St. Rank held Fortress Biotech as of Q4 2019.

Based on Spark Investment Management's 13F filing for Q4 2019, filed 11 Feb 2020.